Nutra Pharma Corporation (NPHC) Proves Strength in Numbers Can Make a Difference
A biotechnology company, Nutra Pharma Corporation (OTCQB: NPHC) focuses on acquiring, licensing, and commercializing pharmaceutical products and technologies. The company concentrates on preventing and treating neurological disorders, cancer, and autoimmune and infectious diseases. Currently, Nutra Pharma offers Nyloxin® and Nyloxin® Extra Strength, the only non-narcotic and non-addictive treatments for severe pain that are sold over-the-counter. The company also markets Pet Pain-Away, an over-the-counter pain reliever for beloved pets. Furthermore, its multiple sclerosis and HIV applications are ready to move into phase II clinical trials. Through its two wholly-owned subsidiaries, Designer Diagnostics and ReceptoPharm, Nutra Pharma has already been able to…